{
  "paper_metadata": {
    "pmid": "38355834",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5945delT",
      "protein_notation": "p.S1982Rfs*22",
      "genomic_position": "Exon 11",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "56-year-old male",
        "phenotype": "metastatic castration-resistant prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 9,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 90.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 56,
          "age_at_onset": null,
          "age_at_diagnosis": 56,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Gleason 9 (5+4) prostate adenocarcinoma metastatic to the bone and lymph nodes",
          "evidence_sentence": "A 56-year-old man with a germline BRCA2 mutation (S1982Rfs*22, exon 11) was found to have a prostate-specific antigen (PSA) of 32\u2009ng/ml and subsequently diagnosed with Gleason 9 (5\u2009+\u20094) prostate adenocarcinoma metastatic to the bone and lymph nodes."
        }
      ],
      "functional_data": {
        "summary": "The reversion mutations are predicted to restore BRCA2 function by re-establishing the open reading frame or excising the germline mutation.",
        "assays": [
          "NGS using MSK-ACCESS",
          "NGS using MSK-IMPACT",
          "whole exome sequencing (WES)"
        ]
      },
      "segregation_data": "The presence of the BRCA2 mutation is associated with the disease in the patient.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The patient exhibited extensive intratumoral heterogeneity with multiple BRCA2 reversion mutations.",
      "key_quotes": [
        "Genomic sequencing of 11 sites of metastatic disease demonstrated extensive intratumoral heterogeneity, with ten unique BRCA2 reversion mutations across ten sites.",
        "The 10 reversion mutations identified on autopsy are predicted to re-establish BRCA2 function by restoring the open reading frame (7 mutations) or excising the germline mutation (3 mutations)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding BRCA2 variants and penetrance were successfully extracted."
  }
}